🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this multicentric, prospective cohort study, candesartan showed effectiveness in the preventive treatment of migraine, including chronic migraine and treatment resistant patients. It was well tolerated in most cases. doi.pulse.ly/x92ozp9akc #migraine #MigraineAwarenessMonth

Join Nina Riggins, our Social Media Editor, as she sits down with Dr David Garcia-Azorin, to discuss their paper published in Cephalalgia. Interview youtube.pulse.ly/r4p9uj1sva Paper journals.sagepub.com/doi/full/10.11… #headache #migraine #citation

EAN participates in the 4th Conference of the African Academy of Neurology eanpages.org/2024/07/19/ean… Matilde Leonardi

Breaking News "International Headache Society global practice recommendations for the acute pharmacological treatment of migraine" is published. Visit the link to access the paper sagepub.pulse.ly/61if3tqplo #headache #migraine #guideline

Super useful guideline published by Cephalalgia International Headache Society I have summarized "answers to 17 questions", reported in table 2 of the paper. journals.sagepub.com/doi/10.1177/03… [Never use any medication without discussing with your doctor]

¡Enhorabuena a todos los compañeros de la Unidad de Cefaleas! 👏🏻👏🏻 David García Azorín Angel L Guerrero

📰"Real-World Evaluation of the Tolerability to #OnabotulinumToxin A: The RETO Study" is an article published in #mdpitoxins. Read this feature paper at: mdpi.com/1984876

We're thrilled to announce the appointment of David Garcia Azorin and Cedric Gollion as the new Graphical Abstract Editors for Cephalalgia! Their expertise will help us enhance the visual presentation of cutting-edge headache research. Stay tuned for more engaging content!

We're thrilled to announce the appointment of David Garcia Azorin and Cedric Gollion as the new Graphical Abstract Editors for Cephalalgia! Their expertise will help us enhance the visual presentation of cutting-edge headache research. Stay tuned for more engaging content!

📌🍾Our paper is out🥂Of the many results from the European survey, what strikes me is that 17% of the 47 national neurological societies had NO CONTACTS AT ALL WITH ANY NEUROLOGICAL PATIENTS ASSOCIATIONS of the respective country. So much to do in Europe!EAN is ready to support!

📢 Announcing the 2024 IHS Headache Science Award Winners! IHS is thrilled to recognize two exceptional researchers making strides in the headache field. 🏆 Mid-career Award: Dr. David García Azorín Based at the University of Valladolid – Hospital Universitario Río Hortega,

David García (David García Azorín), #neurólogo, analiza los beneficios de las últimas innovaciones terapéuticas y los retos en #migraña 👇 redaccionmedica.com/secciones/indu…

Aula Lilly en la Reunión Anual de la SEN 2024 #RASEN24 20, 21 y 22 de noviembre, plazas limitadas; preinscripción en la puerta del aula. En mi caso, haré una exposición entreverada con continuo diálogo, preguntas y respuestas con los asistentes.

🌍💊 Global Disparities in Headache Care A new survey published in Cephalalgia highlights the significant differences in worldwide access to migraine and tension-type headache medications doi.org/10.1177/033310… #headache #migraine

Y también acabamos de presentar en nuestra #RASEN24 el “Informe sobre la relación entre las enfermedades neurológicas y la salud cerebral”. Puedes consultarlo online en: sen.es/pdf/2024/Infor… #Neurología

Seminario de Neurocooperación, con Fundación Recover

🧠🌍 Healthcare professionals in Africa, this one's for you! Join us on November 23, 2024 for the 4th Annual Education in Headache to Healthcare Professionals in Africa (EHHPA)— Register today: ehhpa.submeet.app

This study aimed to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache, which varied greatly across the world. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience Francesca Puledda David García Azorín

This study aimed to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache, which varied greatly across the world. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience Francesca Puledda David García Azorín

The machine-learning based tool holds promise in the prediction of treatment outcomes for patients with migraine undergoing anti-CGRP/R mAbs. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience David García Azorín Marina Romozzi